615 related articles for article (PubMed ID: 16368446)
1. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
[TBL] [Abstract][Full Text] [Related]
2. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
[TBL] [Abstract][Full Text] [Related]
3. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma.
von Berg A; Engelstätter R; Minic P; Sréckovic M; Garcia Garcia ML; Latoś T; Vermeulen JH; Leichtl S; Hellbardt S; Bethke TD
Pediatr Allergy Immunol; 2007 Aug; 18(5):391-400. PubMed ID: 17617808
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma.
Vermeulen JH; Gyurkovits K; Rauer H; Engelstätter R
Respir Med; 2007 Oct; 101(10):2182-91. PubMed ID: 17614270
[TBL] [Abstract][Full Text] [Related]
6. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
7. Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
Ukena D; Biberger C; Steinijans V; von Behren V; Malek R; Weber HH; Beck E; Linnhoff A
Pulm Pharmacol Ther; 2007; 20(5):562-70. PubMed ID: 16962345
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L
Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
[TBL] [Abstract][Full Text] [Related]
10. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
[TBL] [Abstract][Full Text] [Related]
11. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
Shapiro GG; Mendelson LM; Pearlman DS
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
[TBL] [Abstract][Full Text] [Related]
12. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
[TBL] [Abstract][Full Text] [Related]
13. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
Banov CH; Howland WC; Lumry WR
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
White MV; Cruz-Rivera M; Walton-Bowen K
Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
Kerwin EM; Oppenheimer JJ; LaForce C; Parasuraman B; Miller CJ; O'Dowd L; Goldman M
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
[TBL] [Abstract][Full Text] [Related]
19. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma.
Pearlman DS; Berger WE; Kerwin E; Laforce C; Kundu S; Banerji D
J Allergy Clin Immunol; 2005 Dec; 116(6):1206-12. PubMed ID: 16337447
[TBL] [Abstract][Full Text] [Related]
20. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS
Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
